Novel CO2 removal device driven by a renal-replacement system without hemofilter. A first step experimental validation

Thomas Godet(Centre Hospitalier Universitaire de Clermont-Ferrand), Jean-Michel Constantin(Sorbonne Université), Élie Zogheib(Centre Hospitalier Universitaire Amiens-Picardie), Matthieu Jabaudon(Centre National de la Recherche Scientifique), Emmanuel Futier(Centre National de la Recherche Scientifique), Alain Combes(Sorbonne Université), Arthur S. Slutsky(St. Michael's Hospital)
Anaesthesia Critical Care & Pain Medicine
June 1, 2015
10.1016/j.accpm.2014.08.006
Cited by 30

Related Papers

Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries
|JAMA|2016|5.9k
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
|Nature Medicine|2005|3.7k
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
|Cell|2020|2.3k
The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material
|Intensive Care Medicine|2012|1.5k